General Catalyst

What if extracting AI insights from enterprise data was as seamless as a Google search? Glean is Work AI for all that gets the job done. An innately curious team of Google search engineers—Arvind, T.R. Vishwanath, Tony, and Piyush—founded Glean to bring a centralized Work AI platform that connects and understands enterprise data to automate everyday workflows. We’ve believed in their vision since the early days. By making company knowledge widely accessible, its customers, like our portfolio companies Instacart and Grammarly, are empowered with enhanced efficiency. “We’re honored to help some of the world’s largest companies adopt AI to transform their businesses. To truly unlock new levels of creativity, productivity, and operational efficiency, AI needs to draw on the full picture of an organization’s knowledge – and it needs to be accessible by everyone. You shouldn’t have to be a prompt engineering expert to find knowledge, generate content, and automate work with AI.” -Arvind Jain, Glean’s CEO & Co-Founder We’re proud to further our partnership with Arvind and the entire team by investing in Glean’s over $260M Series E raise. Fortune exclusive + Glean's blog in the comments?↓

Health and wellness benefits shouldn't be one-size-fits-all. Thatch is a flexible platform that allows employers to give healthcare decisions and choice back to their employees. “We are excited to back the Thatch team as they reimagine the future of health benefits. In the last year, we’ve seen them hire incredible talent, garner a ton of customer love, and ship products quickly. Thatch offers customers a strong value proposition: employees get greater choice and quality on healthcare; employers get more visibility on spend. In the long-term, we hope Thatch helps bring us a step closer to a more ideal version of American healthcare, one driven by fundamental market forces like quality, transparency, and cost.” -GC’s Alex Tran We’re proud to co-lead Thatch’s $38M Series A raise and welcome Chris, Adam, and the entire team to the GC family. Why we invested by Alex & Nathaniel + an Axios exclusive in the comments?↓

?? Two major steps towards European Health Assurance ? We are thrilled to support both Doccla and Neko Health expanding their footprint across Europe this week. These two businesses are taking major steps to advance preventative care, critical for the delivery of Health Assurance. At General Catalyst, our European Health Assurance thesis is to build scaled businesses at the intersection of healthcare and technology across geographies. The health aspirations and care needs are the same for consumers and the vulnerabilities of the health systems are similar. However, the build is not easy; each country presents a unique set of challenges—distinct regulatory frameworks, differing care infrastructure, diverse payment models, and legacy technologies – that add complexity. But for the most ambitious, mission-driven European entrepreneurs, complex problems are the greatest opportunities! Born in Sweden, Doccla and Neko were built by Martin Ratz, Dag Larsson, Daniel Ek and Hjalmar Nilsonne respectively with big visions to scale across borders. While they operate at opposite sides of the acuity spectrum and have different approaches to reimbursement, they share an obsessive focus on building consumer-centric, technology-enhanced platforms that engage people in primary, secondary and tertiary preventive care. Just as most of the successful companies of the last decade have radically changed consumer behaviour, Doccla and Neko are standard bearers in a movement that will fundamentally transform how people approach their health. Since our investment, Doccla has scaled to serve over half of the NHS trusts, reducing emergency department visits by up to 60%. With a ￡35M Series B funding round, Doccla are primed to bring their virtual hospital solutions to France and Germany, bringing the same hospital-grade care to patients in the comfort of their home as in the UK. Neko has facilitated thousands of full body scans in Sweden and uncovered critical health issues that have spared many individuals. Now, with their expansion into the UK, they are cementing their position as the leading destination in Europe for consumers to gain a comprehensive understanding of their health. At General Catalyst, we are committed to creating, investing, partnering and operating to enhance the resilience of European healthcare. We see tremendous value in catalysing this European movement and invite founders, investors and traditional healthcare leaders from across the continent to join us in the pursuit of Health Assurance. The existing 'sick' care system is in a precarious state and can only be transformed into a more proactive, affordable and accessible one if we work together! Hemant Taneja, Jeannette zu Fürstenberg, Paul Kwan, Alexandre Momeni

Doccla helps health systems “get on with care” with virtual wards that create a more proactive, affordable, and equitable healthcare system. This is the epitome of Health Assurance. In 2022, we led Doccla’s Series A raise to support its aligned Health Assurance vision that alleviates healthcare resources and improves patient outcomes, all from the comfort of their homes. To date, Doccla has monitored more than 4 million patient days, and regions implementing Doccla have reduced emergency visits by over 60%. Radical collaboration with health systems, like the UK’s National Health Service (NHS), has proved instrumental to Doccla’s success. The company plans to launch in new European markets and expand its presence in Life Sciences by monitoring adherence to potentially life-saving treatments. “We have a compliance rate of 92-97% for our patients, those are sky-high numbers. This is because we are in very close contact with our patients.” -Martin Ratz, Doccla’s Co-Founder We’re proud to invest in Doccla’s ￡35M Series B raise and deepen our partnership with Martin, Dag, and the entire team. More from Sifted in the comments ↓

“India’s fastest online grocery app.” That’s how Zepto delivers India’s quick commerce future. Zepto offers 10-minute deliveries across grocery and non-grocery categories in high-density cities like Delhi, Mumbai, Kolkata, Bangalore, Chennai, and Hyderabad. With an expansive vision, Zepto is at the helm of modernizing India’s grocery sector, all while delighting customers at every step of the journey.? “I’ve known Aadit and Kaivalya for several years, and they are truly exceptional founders who turned their bold mission to modernize India’s grocery sector into a category-defining company. This is just the beginning of their journey. This is one of our first investments in India following the merger of Venture Highway and General Catalyst. We are thrilled to partner with Zepto, and believe their quick commerce model is setting the standard for the future of e-commerce in India and beyond." -GC’s Neeraj Arora We’re proud to lead Zepto’s $340M financing round and welcome Aadit, Kaivalya, and the entire team to the GC family. Why we invested by Neeraj, Hemant, & Rahul in the comments ↓

Codeium eliminates coding tedium, enabling developers and organizations to dream bigger. By processing 100 million lines of code in an instant, Codeium’s generative AI-powered platform makes coding a superpower for enterprises like our portfolio company, Anduril Industries. Need to adjust all call sites and queries to conform to the semantics of the new API signature or schema? Cortex is the reasoning engine that will get this done so developers can focus on more creative tasks. Forge, Codeium’s code review assistant, expedites code review cycle times and enhances code review culture. “The future of coding isn’t just about writing lines of code faster—it’s about enabling developers to think bigger, push boundaries, and achieve the extraordinary.” -Varun Mohan, Codeium’s Co-Founder & CEO We’re proud to double down on our partnership with Varun, Douglas Chen, and the entire team by leading Codeium’s $150M Series C raise. More from the Codeium team on the raise led by Quentin & Max and a TechCrunch exclusive in the comments ↓

Today, we’re doubling down on Pylon – they are modernizing B2B customer support with a purpose-built platform that helps enterprises like our portfolio company, Applied Intuition, scale support across channels. When we first met Marty, Advith, and Robert, their passion for this problem space was immediately apparent. Before Pylon, many customer support platforms were finetuned for B2C. Pylon prioritizes B2B-specific needs and meets companies where they are—in chat software like Slack, Microsoft Teams, and Discord—to resolve issues promptly, increasing win rates and strengthening customer relationships. We’re proud to deepen our partnership with Marty, Advith, Robert, and the entire team by investing in Pylon’s $17M Series A. Why we invested by Niko, Andrea, & Tamanna & a TechCrunch exclusive in the comments ↓

GC Venture Fellows build the world they want to see. They’re hard-working, energetic, curious, humble, and bold. Sound like you? If you’re a current college student who is passionate about venture capital, startups, tech, or entrepreneurship, GC Venture Fellows wants to hear from you. Applications are open now until September 12th. Apply via link in comments?↓

In most industries, fragile supply chains cause delays. In healthcare, they can cause deaths. That’s why Steve and the Clarium team, the newest member of the GC family, aim to build a more resilient healthcare supply chain. "We've seen firsthand the need for tools to help healthcare executives create resilient supply chains. Clarium's Astra OS is aiming to fill a market gap with its end-to-end enterprise platform for supply chain operations. Through deep integrations and the application of generative AI, we believe Clarium will drive a paradigm shift in supply chain efficiency. We're excited to partner with Steve and the rest of the Clarium team on this next phase of growth as they scale across the country." -GC’s Reva Nohria We’re proud to lead their $10.5M strategic funding round and welcome Steve and the entire team to the GC family. Why we invested by Chris & Reva & a Modern Healthcare exclusive in comments ↓